Inogen (INGN) Research & Development (2013 - 2026)
Inogen's (INGN) quarterly Research & Development came in at $24.8 million in Q2 2026, down 2.23% year-over-year from $25.4 million in Q2 2025, and up 0.9% quarter-over-quarter from $24.6 million in Q1 2026.
Analysis
Inogen (INGN) Research & Development (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Research & Development for 14 consecutive years, with $24.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Research & Development fell 2.23% year-over-year to $24.8 million in Q2 2026; TTM through Jun 2026 was $98.0 million, a 1.7% decrease from a year earlier, with the FY2025 full-year figure at $97.7 million, down 5.22% from the prior year.
- Research & Development was $24.8 million for Q2 2026 at Inogen, up from $24.6 million in the prior quarter.
- Over five years, Research & Development peaked at $33.7 million in Q3 2022 and troughed at $23.1 million in Q4 2025.
- A 5-year average of $26.6 million and a median of $25.9 million in 2023 frame the typical range for Research & Development.
- Across the five-year window, Research & Development climbed 19.2% in 2022 and fell 22.66% in 2023, its largest moves.
- Over 5 years, Research & Development stood at $28.6 million in 2022, then decreased by 10.32% to $25.7 million in 2023, then retreated by 5.84% to $24.2 million in 2024, then slipped by 4.34% to $23.1 million in 2025, then climbed by 7.44% to $24.8 million in 2026.
- The last three Research & Development figures came in at $24.8 million (Q2 2026), $24.6 million (Q1 2026), and $23.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 24.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.82 Mn |
| Mar 31, 2026 | 24.60 Mn |
| Dec 31, 2025 | 23.11 Mn |
| Sep 30, 2025 | 25.44 Mn |
| Jun 30, 2025 | 25.39 Mn |
| Mar 31, 2025 | 23.76 Mn |
| Dec 31, 2024 | 24.16 Mn |
| Sep 30, 2024 | 26.36 Mn |
| Jun 30, 2024 | 25.62 Mn |
| Mar 31, 2024 | 26.94 Mn |
| Dec 31, 2023 | 25.65 Mn |
| Sep 30, 2023 | 26.09 Mn |
| Jun 30, 2023 | 26.91 Mn |
| Mar 31, 2023 | 28.44 Mn |
| Dec 31, 2022 | 28.61 Mn |
| Sep 30, 2022 | 33.73 Mn |
| Jun 30, 2022 | 30.39 Mn |
| Mar 31, 2022 | 28.04 Mn |
| Dec 31, 2021 | 29.71 Mn |
| Sep 30, 2021 | 28.30 Mn |